The role of immunophilin ligands in nerve regeneration

Regenerative Medicine

Volumn 6, Issue 5, 2011, Pages 635-652

  Toll, Edward C ^a   Seifalian, Alexander M ^a   Birchall, Martin A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

immunophilin ligand; nerve regeneration; peripheral nerves; tacrolimus

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; ARGINYLGLYCYLASPARTIC ACID; CYCLOSPORIN A; FK 1706; L 685818; NERVE GROWTH FACTOR; NEUROIMMUNOPHILIN; POLYGLACTIN; TACROLIMUS; UNCLASSIFIED DRUG; V 10367; V 13449; V 13450; V 13629; V 13670;

ALLOGRAFT; CRANIAL NERVE INJURY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; IMMUNE DEFICIENCY; MEDICAL RESEARCH; NERVE FIBER GROWTH; NERVE RECONSTRUCTION; NERVE REGENERATION; NONHUMAN; OPTIC NERVE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REINNERVATION; REVIEW; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANIMALS; IMMUNOPHILINS; LIGANDS; NERVE GROWTH FACTORS; NERVE REGENERATION; OPTIC NERVE; PERIPHERAL NERVES; SPINAL CORD; SPINAL CORD INJURIES; T-LYMPHOCYTES; TACROLIMUS;

EID: 80052911048     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.43     Document Type: Review

References (145)

1. Thomson AW. FK-506 - how much potential? Immunol. Today 10(1), 6-9 (1989).
2. Starzl TE. First international workshop on FK-506. A potential breakthrough in immunosuppression. Proceedings. Transplant Proc. 19(5 Suppl. 6), 1-104 (1987).
3. Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet 2(8670), 1000-1004 (1989). (Pubitemid 19257914)
4. Reitamo S, Rustin M, Harper J, et al. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Br. J. Dermatol. 159(4), 942-951 (2008).
5. Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 40(9), 1249-1255 (1987). (Pubitemid 17138109)
6. Gold BG. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin. Investig. Drugs 9(10), 2331-2342 (2000).
7. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet 353(9161), 1315-1320 (1999). (Pubitemid 29178782)
8. Jablecki J, Kaczmarzyk L, Domanasiewicz A, et al. First Polish forearm transplantation - final report (outcome after 4 years). Ann. Transplant. 15(2), 61-67 (2010).
9. Siemionow MZ, Papay F, Djohan R, et al. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast. Reconstr. Surg. 125(1), 111-122 (2010).
10. Strome M. Human laryngeal transplantation: considerations and implications. Microsurgery 20(8), 372-374 (2000). (Pubitemid 32044142)
11. Aldape RA, Futer O, DeCenzo MT, et al. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. J. Biol. Chem. 267(23), 16029-16032 (1992).
12. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13(4), 136-142 (1992).
13. Liu D, McIlvain HB, Fennell M, et al. Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells. J. Neurosci. Methods 163(2), 310-320 (2007). (Pubitemid 46874607)
14. Steiner JP, Connolly MA, Valentine HL, et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3(4), 421-428 (1997). (Pubitemid 27145684)
15. Wang MS, Zeleny-Pooley M, Gold BG. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 282(2), 1084-1093 (1997). (Pubitemid 27340215)
16. Gold BG, Storm-Dickerson T, Austin DR. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6, 287-296 (1994). (Pubitemid 24184243)
17. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15(11), 7509-7516 (1995).
18. Gold BG, Zeleny-Pooley M, Wang MS, Chaturvedi P, Armistead DM. A nonimmunosuppressant FKBP12 ligand increases nerve regeneration. Exp. Neurol. 147(2), 269-278 (1997). (Pubitemid 27497289)
19. Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289(3), 1202-1210 (1999). (Pubitemid 29246645)
20. Pratt WB. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med. 217(4), 420-434 (1998).
21. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371(6495), 336-339 (1994). (Pubitemid 24300615)
22. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17(18), 6939-6946 (1997). (Pubitemid 27427872)
23. Intiso D, Grimaldi G, Russo M, et al. Functional outcome and health status of injured patients with peripheral nerve lesions. Injury 41(5), 540-543 (2010).
24. Kingham PJ, Terenghi G. Bioengineered nerve regeneration and muscle reinnervation. J. Anat. 209(4), 511-526 (2006). (Pubitemid 44473319)
25. Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J. Exp. Med. 165(4), 1218-1223 (1987). (Pubitemid 17064518)
26. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 194(Pt 1), 1-14 (1999). (Pubitemid 29126690)
27. Kobayashi J, Mackinnon SE, Watanabe O, et al. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve 20(7), 858-866 (1997). (Pubitemid 27250672)
28. Millesi H. Microsurgery of peripheral nerves. Hand 5(2), 157-160 (1973).
29. Pabari A, Yang SY, Seifalian AM, Mosahebi A. Modern surgical management of peripheral nerve gap. J. Plast. Reconstr. Aesthet. Surg. 63(12), 1941-1948 (2010).
30. Driscoll PJ, Glasby MA, Lawson GM. An in vivo study of peripheral nerves in continuity: biomechanical and physiological responses to elongation. J. Orthop. Res. 20(2), 370-375 (2002). (Pubitemid 34218285)
31. Ray WZ, Mackinnon SE. Clinical outcomes following median to radial nerve transfers. J. Hand. Surg. Am. 36(2), 201-208 (2011).
32. Brown JM, Yee A, Mackinnon SE. Distal median to ulnar nerve transfers to restore ulnar motor and sensory function within the hand: technical nuances. Neurosurgery 65(5), 966-977; discussion 977-968 (2009).
33. Tos P, Geuna S, Papalia I, et al. Experimental and clinical employment of end-to-side coaptation: our experience. Acta Neurochir. (Suppl. 108), 241-245 (2011).
34. Haastert K, Joswig H, Jaschke KA, Samii M, Grothe C. Nerve repair by end-to-side nerve coaptation: histologic and morphometric evaluation of axonal origin in a rat sciatic nerve model. Neurosurgery 66(3), 567-576; discussion 576-567 (2010).
35. Kehoe S, Zhang XF, Boyd D. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury doi: 10.1016/j. injury.2010.12.030 (2011) (Epub ahead of print).
36. Meek MF, Coert JH. US Food and Drug Administration/Conformit Europe - approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Ann. Plast. Surg. 60(4), 466-472 (2008).
37. Lohmeyer JA, Siemers F, Machens HG, Mailander P. The clinical use of artificial nerve conduits for digital nerve repair: a prospective cohort study and literature review. J. Reconstr. Microsurg. 25(1), 55-61 (2009).
38. Farole A, Jamal BT. A bioabsorbable collagen nerve cuff (NeuraGen) for repair of lingual and inferior alveolar nerve injuries: a case series. J. Oral Maxillofac. Surg. 66(10), 2058-2062 (2008).
39. Bushnell BD, McWilliams AD, Whitener GB, Messer TM. Early clinical experience with collagen nerve tubes in digital nerve repair. J. Hand. Surg. Am. 33(7), 1081-1087 (2008).
40. Dellon AL, Maloney CT Jr. Salvage of sensation in a hallux-to-thumb transfer by nerve tube reconstruction. J. Hand. Surg. Am. 31(9), 1495-1498 (2006). (Pubitemid 44767719)
41. Rosson GD, Williams EH, Dellon AL. Motor nerve regeneration across a conduit. Microsurgery 29(2), 107-114 (2009).
42. Navissano M, Malan F, Carnino R, Battiston B. Neurotube for facial nerve repair. Microsurgery 25(4), 268-271 (2005).
43. Bertleff MJ, Meek MF, Nicolai JP. A prospective clinical evaluation of biodegradable neurolac nerve guides for sensory nerve repair in the hand J. Hand. Surg. Am. 30(3), 513-518 (2005). (Pubitemid 40755158)
44. Jiang X, Lim SH, Mao HQ, Chew SY. Current applications and future perspectives of artificial nerve conduits. Exp. Neurol. 223(1), 86-101 (2010).
45. Sun M, Kingham PJ, Reid AJ, et al. In vitro and in vivo testing of novel ultrathin PCL and PCL/PLA blend films as peripheral nerve conduit. J. Biomed. Mater. Res. A 93(4), 1470-1481 (2010).
46. de Ruiter GC, Spinner RJ, Malessy MJ, et al. Accuracy of motor axon regeneration across autograft, single-lumen, and multichannel poly(lactic-co-glycolic acid) nerve tubes. Neurosurgery 63(1), 144-153; discussion 153-145 (2008).
47. Bini TB, Gao S, Xu X, et al. Peripheral nerve regeneration by microbraided poly(l-lactide-co-glycolide) biodegradable polymer fibers. J. Biomed. Mater. Res. A 68(2), 286-295 (2004). (Pubitemid 38524722)
48. Wang S, Wan AC, Xu X, et al. A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials 22(10), 1157-1169 (2001). (Pubitemid 32229940)
49. Wan AC, Mao HQ, Wang S, et al. Fabrication of poly(phosphoester) nerve guides by immersion precipitation and the control of porosity. Biomaterials 22(10), 1147-1156 (2001). (Pubitemid 32229939)
50. Katayama Y, Montenegro R, Freier T, et al. Coil-reinforced hydrogel tubes promote nerve regeneration equivalent to that of nerve autografts. Biomaterials 27(3), 505-518 (2006). (Pubitemid 41457253)
51. Magnaghi V, Conte V, Procacci P, et al. Biological performance of a novel biodegradable polyamidoamine hydrogel as guide for peripheral nerve regeneration. J. Biomed. Mater. Res. A 98(1), 19-30 (2011).
52. Hill PS, Apel PJ, Barnwell J, et al. Repair of peripheral nerve defects in rabbits using keratin hydrogel scaffolds. Tissue Eng. Part A 17(11-12), 1499-1505 (2011).
53. Pettersson J, Kalbermatten D, McGrath A, Novikova LN. Biodegradable fibrin conduit promotes long-term regeneration after peripheral nerve injury in adult rats. J. Plast. Reconstr. Aesthet. Surg. 63(11), 1893-1899 (2010).
54. Scott JB, Afshari M, Kotek R, Saul JM. The promotion of axon extension in vitro using polymer-templated fibrin scaffolds. Biomaterials 32(21), 4830-4839 (2011).
55. Sufan W, Suzuki Y, Tanihara M, et al. Sciatic nerve regeneration through alginate with tubulation or nontubulation repair in cat. J. Neurotrauma 18(3), 329-338 (2001). (Pubitemid 32230635)
56. Gu J, Hu W, Deng A, et al. Surgical repair of a 30 mm long human median nerve defect in the distal forearm by implantation of a chitosan-PGA nerve guidance conduit. J. Tissue Eng. Regen. Med. doi: 10.1002/term.407 (2011) (Epub ahead of print).
57. Xie F, Li QF, Gu B, Liu K, Shen GX. In vitro and in vivo evaluation of a biodegradable chitosan-PLA composite peripheral nerve guide conduit material. Microsurgery 28(6), 471-479 (2008).
58. Inada Y, Morimoto S, Takakura Y, Nakamura T. Regeneration of peripheral nerve gaps with a polyglycolic acid-collagen tube. Neurosurgery 55(3), 640-646; discussion 646-648 (2004). (Pubitemid 39186860)
59. Inada Y, Hosoi H, Yamashita A, et al. Regeneration of peripheral motor nerve gaps with a polyglycolic acid-collagen tube: technical case report. Neurosurgery 61(5), E1105-E1107; discussion E1107 (2007). (Pubitemid 350306991)
60. de Boer R, Knight AM, Borntraeger A, et al. Rat sciatic nerve repair with a poly-lactic-co-glycolic acid scaffold and nerve growth factor releasing microspheres. Microsurgery 31(4), 293-302 (2011).
61. Liu JJ, Wang CY, Wang JG, Ruan HJ, Fan CY. Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning. J. Biomed. Mater. Res. A 96(1), 13-20 (2011).
62. Pfister LA, Alther E, Papaloizos M, Merkle HP, Gander B. Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur. J. Pharm. Biopharm. 69(2), 563-572 (2008).
63. Moore AM, Wood MD, Chenard K, et al. Controlled delivery of glial cell line-derived neurotrophic factor enhances motor nerve regeneration. J. Hand. Surg. Am. 35(12), 2008-2017 (2010).
64. Wood MD, Moore AM, Hunter DA, et al. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater. 5(4), 959-968 (2009).
65. Midha R, Munro CA, Dalton PD, Tator CH, Shoichet MS. Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J. Neurosurg. 99(3), 555-565 (2003). (Pubitemid 37040419)
66. Wang S, Cai Q, Hou J, et al. Acceleration effect of basic fibroblast growth factor on the regeneration of peripheral nerve through a 15-mm gap. J. Biomed. Mater. Res. A 66(3), 522-531 (2003). (Pubitemid 37517198)
67. Mohanna PN, Terenghi G, Wiberg M. Composite PHB-GGF conduit for long nerve gap repair: a long-term evaluation. Scand. J. Plast. Reconstr. Surg. Hand Surg. 39(3), 129-137 (2005). (Pubitemid 40868423)
68. Zhang J, Lineaweaver WC, Oswald T, et al. Ciliary neurotrophic factor for acceleration of peripheral nerve regeneration: an experimental study. J. Reconstr. Microsurg. 20(4), 323-327 (2004). (Pubitemid 38580513)
69. Mosahebi A, Wiberg M, Terenghi G. Addition of fibronectin to alginate matrix improves peripheral nerve regeneration in tissue-engineered conduits. Tissue Eng. 9(2), 209-218 (2003). (Pubitemid 36944171)
70. Armstrong SJ, Wiberg M, Terenghi G, Kingham PJ. ECM molecules mediate both Schwann cell proliferation and activation to enhance neurite outgrowth. Tissue Eng. 13(12), 2863-2870 (2007). (Pubitemid 350233079)
71. Koh HS, Yong T, Teo WE, et al. In vivo study of novel nanofibrous intra-luminal guidance channels to promote nerve regeneration. J. Neural Eng. 7(4), 046003 (2010).
72. Cao J, Sun C, Zhao H, et al. The use of laminin modified linear ordered collagen scaffolds loaded with laminin-binding ciliary neurotrophic factor for sciatic nerve regeneration in rats. Biomaterials 32(16), 3939-3948 (2011).
73. Yao L, Billiar KL, Windebank AJ, Pandit A. Multichanneled collagen conduits for peripheral nerve regeneration: design, fabrication, and characterization. Tissue Eng. Part C Methods 16(6), 1585-1596 (2010).
74. George PM, Saigal R, Lawlor MW, et al. Three-dimensional conductive constructs for nerve regeneration. J. Biomed. Mater. Res. A 91(2), 519-527 (2009).
75. Cai J, Peng X, Nelson KD, Eberhart R, Smith GM. Permeable guidance channels containing microfilament scaffolds enhance axon growth and maturation. J. Biomed. Mater. Res. A 75(2), 374-386 (2005). (Pubitemid 41463907)
76. Gamez E, Goto Y, Nagata K, et al. Photofabricated gelatin-based nerve conduits: nerve tissue regeneration potentials. Cell Transplant. 13(5), 549-564 (2004). (Pubitemid 39557434)
77. Lin YL, Jen JC, Hsu SH, Chiu IM. Sciatic nerve repair by microgrooved nerve conduits made of chitosan-gold nanocomposites. Surg. Neurol. 70(Suppl. 1), 9-18 (2008).
78. Sun M, McGowan M, Kingham PJ, Terenghi G, Downes S. Novel thin-walled nerve conduit with microgrooved surface patterns for enhanced peripheral nerve repair. J. Mater. Sci. Mater. Med. 21(10), 2765-2774 (2010).
79. Kim SM, Lee SK, Lee JH. Peripheral nerve regeneration using a three dimensionally cultured schwann cell conduit. J. Craniofac. Surg. 18(3), 475-488 (2007).
80. Yang Y, Yuan X, Ding F, et al. Repair of rat sciatic nerve gap by a silk fibroin-based scaffold added with bone marrow mesenchymal stem cells. Tissue Eng. Part A doi: 10.1089/ten.tea.2010.0633 (2011) (Epub ahead of print).
81. Ladak A, Olson J, Tredget EE, Gordon T. Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model. Exp. Neurol. 228(2), 242-252 (2011).
82. Zheng L, Cui HF. Use of chitosan conduit combined with bone marrow mesenchymal stem cells for promoting peripheral nerve regeneration. J. Mater. Sci. Mater. Med. 21(5), 1713-1720 (2010).
83. Erba P, Mantovani C, Kalbermatten DF, et al. Regeneration potential and survival of transplanted undifferentiated adipose tissue-derived stem cells in peripheral nerve conduits. J. Plast. Reconstr. Aesthet. Surg. 63(12), e811-e817 (2010).
84. di Summa PG, Kingham PJ, Raffoul W, et al. Adipose-derived stem cells enhance peripheral nerve regeneration. J. Plast. Reconstr. Aesthet. Surg. 63(9), 1544-1552 (2010).
85. di Summa PG, Kalbermatten DF, Pralong E, et al. Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts. Neuroscience 181, 278-291 (2011).
86. Ray WZ, Kale SS, Kasukurthi R, et al. Effect of cold nerve allograft preservation on antigen presentation and rejection. J. Neurosurg. 114(1), 256-262 (2011).
87. Rustemeyer J, Dicke U. Allografting combined with systemic FK506 produces greater functional recovery than conduit implantation in a rat model of sciatic nerve. Injury J. Reconstr. Microsurg. 26(2), 123-129 (2010).
88. Moore AM, Macewan M, Santosa KB, et al. Acellular nerve allografts in peripheral nerve regeneration: a comparative study. Muscle Nerve 44(2), 221-234 (2011).
89. Hu M, Zhang L, Niu Y, et al. Repair of whole rabbit facial nerve defects using facial nerve allografts. J. Oral Maxillofac. Surg. 68(9), 2196-2206 (2010).
90. Ehashi T, Nishigaito A, Fujisato T, Moritan Y, Yamaoka T. Peripheral nerve regeneration and electrophysiological recovery with CIP-treated allogeneic acellular nerves. J. Biomater. Sci. Polym. Ed. 22(4-6), 627-640 (2011).
91. Lee M, Doolabh VB, Mackinnon SE, Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 23(4), 633-640 (2000). (Pubitemid 30164791)
92. Kumano K, Wang G, Endo T, Kuwao S. FK 506-induced nephrotoxicity in rats. Transplant Proc. 23(1 Pt 1), 512-515 (1991).
93. Brenner MJ, Mackinnon SE, Rickman SR, et al. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation. Restor. Neurol. Neurosci. 23(3-4), 237-249 (2005). (Pubitemid 41132444)
94. Yang RK, Lowe JB 3rd, Sobol JB, et al. Dose-dependent effects of FK506 on neuroregeneration in a rat model. Plast. Reconstr. Surg. 112(7), 1832-1840 (2003). (Pubitemid 39195831)
95. Konofaos P, Burns J, Terzis JK. Effect of low-dose FK506 after contralateral C7 transfer to the musculocutaneous nerve: a study in rats. J. Reconstr. Microsurg. 26(4), 225-233 (2010).
96. Terzis JK, Konofaos P. Low-dose FK506 after contralateral C7 transfer to the musculocutaneous nerve using two different tubes: a study in rats. Ann. Plast. Surg. 64(5), 622-631 (2010).
97. Udina E, Ceballos D, Verdu E, Gold BG, Navarro X. Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve 26(3), 348-355 (2002). (Pubitemid 34977012)
98. Rosenstiel P, Schramm P, Isenmann S, et al. Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo. J. Neurotrauma 20(3), 297-307 (2003). (Pubitemid 36373827)
99. Chang HY, Takei K, Sydor AM, et al. Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. Nature 376(6542), 686-690 (1995).
100. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl Acad. Sci. USA 91(8), 3191-3195 (1994). (Pubitemid 24130201)
101. Udina E, Ceballos D, Gold BG, Navarro X. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp. Neurol. 183(1), 220-231 (2003). (Pubitemid 37075872)
102. Sobol JB, Lowe IJ, Yang RK, et al. Effects of delaying FK506 administration on neuroregeneration in a rodent model. J. Reconstr. Microsurg. 19(2), 113-118 (2003). (Pubitemid 36397555)
103. Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor. Neurol. Neurosci. 17(1), 39-44 (2000).
104. Doolabh VB, Mackinnon SE. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast. Reconstr. Surg. 103(7), 1928-1936 (1999). (Pubitemid 29251992)
105. Udina E, Gold BG, Navarro X. Comparison of continuous and discontinuous FK506 administration on autograft or allograft repair of sciatic nerve resection. Muscle Nerve 29(6), 812-822 (2004). (Pubitemid 38720818)
106. Gold BG, Gordon HS, Wang MS. Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. Neurosci. Lett. 267(1), 33-36 (1999). (Pubitemid 29251616)
107. Snyder AK, Fox IK, Nichols CM, et al. Neuroregenerative effects of preinjury FK-506 administration. Plast. Reconstr. Surg. 118(2), 360-367 (2006). (Pubitemid 44162040)
108. Kirsch M, Terheggen U, Hofmann HD. Ciliary neurotrophic factor is an early lesion-induced retrograde signal for axotomized facial motoneurons. Mol. Cell. Neurosci. 24(1), 130-138 (2003). (Pubitemid 37194539)
109. Richardson PM, Miao T, Wu D, et al. Responses of the nerve cell body to axotomy. Neurosurgery 65(Suppl. 4), A74-A79 (2009).
110. Tuck E, Cavalli V. Roles of membrane trafficking in nerve repair and regeneration. Commun. Integr. Biol. 3(3), 209-214 (2010).
111. Jifeng H, Dezhong L, Qiongjiao Y, Huayong Z, Shipu L. Evaluation of PRGD/FK506/NGF conduits for peripheral nerve regeneration in rats. Neurol. India 58(3), 384-391 (2010).
112. Li X, Wang W, Wei G, et al. Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regeneration. Biotechnol. Lett. 32(9), 1333-1337 (2010).
113. Becker DB, Jensen JN, Myckatyn TM, et al. Effects of FKBP12 ligands following tibial nerve injury in rats. J. Reconstr. Microsurg. 16(8), 613-620 (2000).
114. Dumont FJ, Staruch MJ, Koprak SL, et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK- 506 and rapamycin. J. Exp. Med. 176(3), 751-760 (1992).
115. Price RD, Yamaji T, Yamamoto H, et al. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action. Eur. J. Pharmacol. 509(1), 11-19 (2005). (Pubitemid 40248780)
116. Gold BG, Armistead DM, Wang MS. Non-FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration. J. Neurosci. Res. 80(1), 56-65 (2005). (Pubitemid 40577293)
117. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J. Urol. 171(1), 495-500 (2004). (Pubitemid 37549218)
118. Valentine H, Chen Y, Guo H, et al. Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms. Eur. Urol. 51(6), 1724-1731 (2007). (Pubitemid 46634741)
119. Steiner JP, Hamilton GS, Ross DT, et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl Acad. Sci. USA 94(5), 2019-2024 (1997). (Pubitemid 27113954)
120. Khan Z, Ferrari G, Kasper M, et al. The non-immunosuppressive immunophilin ligand GPI-1046 potently stimulates regenerating axon growth from adult mouse dorsal root ganglia cultured in Matrigel. Neuroscience 114(3), 601-609 (2002). (Pubitemid 35247648)
121. Diaz LM, Steele MH, Guerra AB, et al. The role of topically administered FK506 (tacrolimus) at the time of facial nerve repair using entubulation neurorrhaphy in a rabbit model. Ann. Plast. Surg. 52(4), 407-413 (2004). (Pubitemid 38500362)
122. Yeh C, Bowers D, Hadlock TA. Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch. Facial Plast. Surg. 9(5), 333-339 (2007).
123. Lundborg G. A 25-year perspective of peripheral nerve surgery: evolving neuroscientific concepts and clinical significance. J. Hand. Surg. Am. 25(3), 391-414 (2000). (Pubitemid 30354299)
124. Hontanilla B, Auba C, Arocha J, Gorria O. Nerve regeneration through nerve autografts and cold preserved allografts using tacrolimus (FK506) in a facial paralysis model: A topographical and neurophysiological study in monkeys. Neurosurgery 58(4), 768-779 (2006).
125. Facial Transplantation. Working Party Report (2nd Edition). RCSENG - Council, London, UK (2006)
126. Zhang Y, Luo H, Zhang Z, et al. A nerve graft constructed with xenogeneic acellular nerve matrix and autologous adipose-derived mesenchymal stem cells. Biomaterials 31(20), 5312-5324 (2010).
127. Walsh S, Biernaskie J, Kemp SW, Midha R. Supplementation of acellular nerve grafts with skin derived precursor cells promotes peripheral nerve regeneration. Neuroscience 164(3), 1097-1107 (2009).
128. Margreiter R, Brandacher G, Ninkovic M, et al. A double-hand transplant can be worth the effort! Transplantation 74(1), 85-90 (2002). (Pubitemid 34779216)
129. Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N. Engl. J. Med. 343(7), 468-473 (2000). (Pubitemid 30646486)
130. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N. Engl. J. Med. 357(24), 2451-2460 (2007). (Pubitemid 350272784)
131. Sarikcioglu L, Demir N, Akar Y, Demirtop A. Effect of intrathecal FK506 administration on intraorbital optic nerve crush: an ultrastructural study. Can. J. Ophthalmol. 44(4), 427-430 (2009).
132. Bavetta S, Hamlyn PJ, Burnstock G, Lieberman AR, Anderson PN. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 158(2), 382-393 (1999). (Pubitemid 29382828)
133. Madsen JR, MacDonald P, Irwin N, et al. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154(2), 673-683 (1998). (Pubitemid 29044236)
134. Voda J, Yamaji T, Gold BG. Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats. J. Neurotrauma 22(10), 1150-1161 (2005). (Pubitemid 41532552)
135. Yamaji T, Yamazaki S, Li J, et al. FK1706, a novel non-immunosuppressant neurophilin ligand, ameliorates motor dysfunction following spinal cord injury through its neuroregenerative action. Eur. J. Pharmacol. 591(1-3), 147-152 (2008).
136. Saganova K, Orendacova J, Sulla I Jr, et al. Effects of long-term FK506 administration on functional and histopathological outcome after spinal cord injury in adult rat. Cell. Mol. Neurobiol. 29(6-7), 1045-1051 (2009).
137. Voda J, Hama A, Sagen J. FK506 reduces the severity of cutaneous hypersensitivity in rats with a spinal cord contusion. Neurosci. Res. 58(1), 95-99 (2007). (Pubitemid 46678496)
138. Yeo Y, Basaran OA, Park K. A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation. J. Control. Release 93(2), 161-173 (2003). (Pubitemid 37424032)
139. Udina E, Verdu E, Navarro X. Effects of the immunophilin ligand FK506 on nerve regeneration in collagen guides seeded with Schwann cells in rats. Neurosci. Lett. 357(2), 99-102 (2004). (Pubitemid 38230940)
140. Herdegen T, Fischer G, Gold BG. Immunophilin ligands as a novel treatment for neurological disorders. Trends Pharmacol. Sci. 21(1), 3-5 (2000). (Pubitemid 30102181)
141. Tung TH. Tacrolimus (FK506): safety and applications in reconstructive surgery. Hand (NY) 5(1), 1-8 (2009).
142. Guo X, Dawson VL, Dawson TM. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci. 13(9), 1683-1693 (2001). (Pubitemid 32488058)
143. Wright AK, Miller C, Williams M, Arbuthnott G. Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression. Brain Res. 1216, 78-86 (2008).
144. Brecht S, Waetzig V, Hidding U, et al. FK506 protects against various immune responses and secondary degeneration following cerebral ischemia. Anat. Rec. (Hoboken) 292(12), 1993-2001 (2009).
145. Hospital Episode Statistics Online. Primary Diagnosis: 4 Character 2009-2010 www.hesonline.nhs.uk/Ease/ContentServer?sit eID=1937&categoryID= 214